# A Randomized Study to Determine the Expression of the Furin Protein in Patients With SARS-CoV-2 and Vaccinated Against Coronavirus

> **NCT05104840** · — · TERMINATED · sponsor: **Center Trials & Treatment** · enrollment: 2432 (actual)

## Conditions studied

- COVID-19
- SARS-CoV-2
- Furin
- RGMc Processing
- Paired Basic Amino Acid Cleaving Enzyme (PACE)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05104840
- **Lead sponsor:** Center Trials & Treatment
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2022-08-10
- **Primary completion:** 2023-03-27
- **Final completion:** 2023-03-28
- **Target enrollment:** 2432 (ACTUAL)
- **Why stopped:** the company is liquidated
- **Last updated:** 2023-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05104840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05104840, "A Randomized Study to Determine the Expression of the Furin Protein in Patients With SARS-CoV-2 and Vaccinated Against Coronavirus". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05104840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*